MERCK Kommanditgesellschaft auf Aktien
MER
Pozycja w akcjach
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Cena akcji
$171.67
Ostatnia synchronizacja: 2026-07-13
Kapitalizacja rynkowa
$74.64B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-
Kraj
DE
Handel MERCK Kommanditgesellschaft auf Aktien (MER)
Kategoria
Healthcare
Zyski dla MERCK Kommanditgesellschaft auf Aktien (MER)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych MERCK Kommanditgesellschaft auf Aktien, obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy MERCK Kommanditgesellschaft auf Aktien od 2002 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2025 | $3.88B | -15.61% |
| 2022 | $4.60B | 3.06% |
| 2021 | $4.46B | 39.31% |
| 2020 | $3.20B | 64.54% |
| 2019 | $1.95B | 15.95% |
| 2018 | $1.68B | -37.09% |
| 2017 | $2.67B | 17.75% |
| 2016 | $2.27B | 40.42% |
| 2015 | $1.61B | -14.32% |
| 2014 | $1.88B | -1.34% |
| 2013 | $1.91B | 104.18% |
| 2012 | $935.24M | -15.11% |
| 2011 | $1.10B | -4.30% |
| 2010 | $1.15B | 65.07% |
| 2009 | $697.43M | -12.95% |
| 2008 | $801.20M | -594.25% |
| 2007 | $-162.10M | -109.67% |
| 2006 | $1.68B | 58.74% |
| 2005 | $1.06B | -18.97% |
| 2004 | $1.30B | 144.81% |
| 2003 | $532.17M | 23.21% |
| 2002 | $431.92M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
|
| - | - |
CN
|
